| Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: in vitro and in vivo study YJ Wang, YK Zhang, GN Zhang, SB Al Rihani, MN Wei, P Gupta, ... Cancer letters 396, 145-154, 2017 | 66 | 2017 |
| Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters YK Zhang, GN Zhang, YJ Wang, BA Patel, TT Talele, DH Yang, ZS Chen Scientific reports 6 (1), 25694, 2016 | 63 | 2016 |
| β-Elemene, a compound derived from Rhizoma zedoariae, reverses multidrug resistance mediated by the ABCB1 transporter HQ Guo, GN Zhang, YJ Wang, YK Zhang, K Sodani, TT Talele, CR Ashby, ... Oncology reports 31 (2), 858-866, 2014 | 59 | 2014 |
| The reversal of antineoplastic drug resistance in cancer cells by β-elemene GN Zhang, CR Ashby, YK Zhang, ZS Chen, H Guo Chinese journal of cancer 34, 1-8, 2015 | 57 | 2015 |
| Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: in vitro and in vivo GN Zhang, YK Zhang, YJ Wang, P Gupta, CR Ashby Jr, S Alqahtani, ... Cancer letters 424, 19-29, 2018 | 54 | 2018 |
| Semi-synthetic ocotillol analogues as selective ABCB1-mediated drug resistance reversal agents YK Zhang, H Zhang, GN Zhang, YJ Wang, RJ Kathawala, R Si, BA Patel, ... Oncotarget 6 (27), 24277, 2015 | 42 | 2015 |
| Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer YK Zhang, YJ Wang, ZN Lei, GN Zhang, XY Zhang, D Wang, SB Al-Rihani, ... Cancer letters 442, 104-112, 2019 | 35 | 2019 |
| Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881 YK Zhang, XY Zhang, GN Zhang, YJ Wang, H Xu, D Zhang, S Shukla, ... Biochemical pharmacology 132, 29-37, 2017 | 32 | 2017 |
| Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin YJ Wang, Y Huang, N Anreddy, GN Zhang, YK Zhang, M Xie, D Lin, ... Oncotarget 7 (5), 5877, 2016 | 31 | 2016 |
| Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib GN Zhang, YK Zhang, YJ Wang, AM Barbuti, XJ Zhu, XY Yu, AW Wen, ... Pharmacological research 119, 89-98, 2017 | 29 | 2017 |
| EGFR and HER2 inhibitors as sensitizing agents for cancer chemotherapy AM Barbuti, GN Zhang, P Gupta, S Narayanan, ZS Chen Protein kinase inhibitors as sensitizing agents for chemotherapy, 1-11, 2019 | 17 | 2019 |
| Thiazole-valine peptidomimetic (TTT-28) antagonizes multidrug resistance in vitro and in vivo by selectively inhibiting the efflux activity of ABCB1 YJ Wang, BA Patel, N Anreddy, YK Zhang, GN Zhang, S Alqahtani, ... Scientific reports 7 (1), 42106, 2017 | 14 | 2017 |
| Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia P Gupta, GN Zhang, AM Barbuti, X Zhang, N Karadkhelkar, J Zhou, ... Cancer Letters 472, 132-141, 2020 | 12 | 2020 |
| Lipid–Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo GN Zhang, P Gupta, M Wang, AM Barbuti, CR Ashby Jr, YK Zhang, ... Cancers 12 (2), 498, 2020 | 9 | 2020 |
| Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer YJ Wang, YK Zhang, GN Zhang, SB Al Rihani, MN Wei, P Gupta, ... vitro, 0 | 8 | |
| MG53 inhibits cellular proliferation and tumor progression in colorectal carcinoma P Gupta, H Li, GN Zhang, AM Barbuti, Y Yang, P Lin, C Cai, T Tan, J Ma, ... International Journal of Biological Sciences 18 (14), 5221, 2022 | 6 | 2022 |
| The Reversal of ABCG2-Mediated Multidrug Resistance (MDR) by PD153035, an Inhibitor of EGFR: IN VITRO and IN VIVO Study G Zhang St. John's University, 2018 | | 2018 |
| S116836 overcomes BCR-ABL T3151 Mutation Mediated Imatinib Resistance in Chronic Myeloid Leukemia P Gupta St. John's University (New York), 2018 | | 2018 |
| Regorafenib (Stivarga®) reverses BCRP-mediated multidrug resistance in vitro and in vivo YK Zhang, YJ Wang, GN Zhang, WJ Zhang, MN Wei, Z Shi, ZS Chen Cancer Research 77 (13_Supplement), 1192-1192, 2017 | | 2017 |
| Modulating the function of multidrug resistance ABCG2 transporter by tyrosine kinases receptor inhibitor cabozantinib G Zhang, YK Zhang, YJ Wang, ZS Chen Cancer Research 76 (14_Supplement), 4684-4684, 2016 | | 2016 |
